Zai Lab (ZLAB) Enterprise Value (2016 - 2026)
Zai Lab (ZLAB) posted Enterprise Value of -$751.3 million for Q1 2026, up 3.62% sequentially from -$779.6 million in Q4 2025, and up 12.36% YoY from -$668.7 million in Q1 2025.
Zai Lab (ZLAB) Enterprise Value (2016 - 2026) Analysis & Trends
Zai Lab has reported Enterprise Value for 11 years, with the latest figure at -$751.3 million in Q1 2026.
- Quarterly Enterprise Value rose 12.36% year-over-year to -$751.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$751.3 million (up 12.36% YoY) and the FY2025 annual result came in at -$779.6 million, changed 0.01% from the prior year.
- Enterprise Value advanced to -$751.3 million in Q1 2026 per ZLAB's latest filing, from -$779.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$716.1 million in Q3 2024 and troughed at -$1.3 billion in Q1 2022.
- A 5-year average of -$890.7 million and a median of -$820.4 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value decreased 29.49% in 2022, then soared 30.37% in 2023.
- Over 5 years, Enterprise Value stood at -$1.0 billion in 2022, then advanced by 20.03% to -$806.5 million in 2023, then climbed by 3.32% to -$779.7 million in 2024, then rose by 0.01% to -$779.6 million in 2025, then climbed by 3.62% to -$751.3 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$751.3 million, -$779.6 million, and -$817.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | -707.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -707.52 Mn |
| Mar 31, 2026 | -751.32 Mn |
| Dec 31, 2025 | -779.57 Mn |
| Sep 30, 2025 | -817.16 Mn |
| Jun 30, 2025 | -832.27 Mn |
| Mar 31, 2025 | -857.26 Mn |
| Dec 31, 2024 | -779.67 Mn |
| Sep 30, 2024 | -716.09 Mn |
| Jun 30, 2024 | -730.05 Mn |
| Mar 31, 2024 | -750.78 Mn |
| Dec 31, 2023 | -806.45 Mn |
| Sep 30, 2023 | -820.41 Mn |
| Jun 30, 2023 | -874.66 Mn |
| Mar 31, 2023 | -930.39 Mn |
| Dec 31, 2022 | -1.01 Bn |
| Sep 30, 2022 | -1.12 Bn |
| Jun 30, 2022 | -1.26 Bn |
| Mar 31, 2022 | -1.31 Bn |
| Dec 31, 2021 | -1.41 Bn |
| Sep 30, 2021 | -1.57 Bn |